Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) on Monday, soared 5.50% from the previous trading day, before settling in for the closing price of $0.18. Within the past 52 weeks, TNXP’s price has moved between $0.12 and $22.14.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 47.76%. With a float of $137.26 million, this company’s outstanding shares have now reached $137.26 million.
Let’s look at the performance matrix of the company that is accounted for 103 employees. In terms of profitability, gross margin is -0.05%, operating margin of -764.06%, and the pretax margin is -1196.11%.
Tonix Pharmaceuticals Holding Corp (TNXP) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Tonix Pharmaceuticals Holding Corp is 0.00%, while institutional ownership is 0.45%.
Tonix Pharmaceuticals Holding Corp (TNXP) Performance Highlights and Predictions
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -58.56 earnings per share (EPS) for the period falling under the consensus outlook (set at -47.68) by -10.88. Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.97 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 47.76% per share during the next fiscal year.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Trading Performance Indicators
Tonix Pharmaceuticals Holding Corp (TNXP) is currently performing well based on its current performance indicators. A quick ratio of 0.72 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -22.15, a number that is poised to hit -2.93 in the next quarter and is forecasted to reach -10.45 in one year’s time.
Technical Analysis of Tonix Pharmaceuticals Holding Corp (TNXP)
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) saw its 5-day average volume 41.76 million, a positive change from its year-to-date volume of 9.92 million. As of the previous 9 days, the stock’s Stochastic %D was 72.49%. Additionally, its Average True Range was 0.03.
During the past 100 days, Tonix Pharmaceuticals Holding Corp’s (TNXP) raw stochastic average was set at 1.32%, which indicates a significant decrease from 84.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 90.70% in the past 14 days, which was lower than the 186.73% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2205, while its 200-day Moving Average is $4.6647. Nevertheless, the first resistance level for the watch stands at $0.2031 in the near term. At $0.2163, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.2291. If the price goes on to break the first support level at $0.1771, it is likely to go to the next support level at $0.1643. Assuming the price breaks the second support level, the third support level stands at $0.1511.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Key Stats
Market capitalization of the company is 26.07 million based on 2,986K outstanding shares. Right now, sales total 7,770 K and income totals -116,660 K. The company made 2,210 K in profit during its latest quarter, and -78,780 K in sales during its previous quarter.
